AstraZeneca plc (AZN) Ordinary US$0.25

Sell:10,688.00pBuy:10,690.00p64.00p (0.60%)

FTSE 100:0.26%
Market closed | Prices delayed by at least 15 minutes
Sell:10,688.00p
Buy:10,690.00p
Change:64.00p (0.60%)
Market closed | Prices delayed by at least 15 minutes
Sell:10,688.00p
Buy:10,690.00p
Change:64.00p (0.60%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
12 December 2023
Anna Olive Magdelene ManzNon-Executive Director
Buy
Regular purchase transaction
487£101.90£49,623.16487
22 November 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
1,000£101.70£101,700.006,000
21 November 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
1,000£101.05£101,052.205,000
5 May 2023
Aradhana SarinCFO
Sell
Regular sell transaction (market)
19,470$74.81$1,456,550.70150,000
28 April 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
2,000£117.01£234,020.004,000

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 May 2023
Aradhana SarinCFO
Sell
Regular sell transaction (market)
19,470$74.81$1,456,550.70150,000
28 April 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
2,000£117.01£234,020.004,000
22 November 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
1,000£101.70£101,700.006,000
21 November 2023
Michel Roger DemareChairman of the Board
Buy
Regular purchase transaction
1,000£101.05£101,052.205,000
12 December 2023
Anna Olive Magdelene ManzNon-Executive Director
Buy
Regular purchase transaction
487£101.90£49,623.16487

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.